Carson Wealth (CWM LLC)’s Solid Biosciences SLDB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$38.1K Buy
5,295
+801
+18% +$5.15K ﹤0.01% 3994
2025
Q4
$25K Buy
4,494
+15
+0.3% +$81 ﹤0.01% 4050
2025
Q3
$28K Sell
4,479
-952
-18% -$5.57K ﹤0.01% 3931
2025
Q2
$26K Sell
5,431
-2,519
-32% -$8.9K ﹤0.01% 3754
2025
Q1
$29K Buy
7,950
+7,898
+15,188% +$33.8K ﹤0.01% 3422
2024
Q4
$0 Sell
52
-1,140
-96% -$6.26K ﹤0.01% 5137
2024
Q3
$8K Buy
+1,192
New +$9.67K ﹤0.01% 3905

Other funds holding SLDB

Carson Wealth (CWM LLC)'s SLDB Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Solid Biosciences (SLDB) stake by 18% in Q1 2026, buying an estimated $5.15K and bringing the position to 5,295 shares worth $38.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3994.

Carson Wealth (CWM LLC) first reported a position in SLDB in Q3 2024 and has held it in 7 quarters since. 150 funds tracked by Wall St. Rank hold SLDB as of Q1 2026.

  • Carson Wealth (CWM LLC) held 5,295 shares of Solid Biosciences worth $38.1K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 801 Solid Biosciences shares in Q1 2026, an estimated $5.15K.
  • Solid Biosciences made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #3994 holding.
  • Carson Wealth (CWM LLC) first reported a position in Solid Biosciences in Q3 2024 and has held it in 7 quarters since.
  • 150 funds tracked by Wall St. Rank held Solid Biosciences as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.